What you should know:
1. Dr. Blanchard served in the interim appointments since February 2020. She’s been on Anika’s board since August 2018.
2. She brings more than 25 years of executive experience to the role.
3. Before joining Anika, Dr. Blanchard served as the president and CEO of Microchips Biotech from 2014 until it sold in November 2019. She previously worked at Zimmer and Southwest Research Institute.
More articles on devices:
AAOS publishes clinical considerations for return to elective surgery
97% of medical practices suffer COVID-19 financial hit: 5 observations for orthopedics
Investor pays $49M for Arizona spine, orthopedic hospital property
